Melts and Messes: Medical and surgical approaches to corneal disasters

My Session Status

When:

10:45, Saturday 2 Jun 2018 (1 hour 30 minutes)

Breaks:

Lunch 12:15 PM to 01:30 PM (1 hour 15 minutes)

Where:

Metro Toronto Convention Centre (South Building) - Room 714 A

Theme:

Cornea

LEARNING OBJECTIVES
At the end of this session, participants will be able to:

Describe medical management of severe corneal disease
Describe surgical management of severe corneal disease

CANMEDS ROLES: Medical Expert, Scholar

Setareh Ziai

Moderator

Dr. Mahshad Darvish

Other Participant

Sonia N. Yeung, MD, PhD, FRCSC

Other Participant

Sub Sessions

Introduction

10:45 - 10:47 | 2 minutes

Besifloxacin ophthalmic suspension in patients with bacterial keratitis: A prospective, randomized clinical study

10:47 - 10:52 | 5 minutes

Ron Jans Clinical Cornea Research AwardAward Winner

RON JANS CLINICAL CORNEA RESEARCH AWARD WINNER Authors: Fatma Zaguia, Michael Ross, Mahshad Darvish, Jean DeschênesAuthor Disclosure Block: F. Zaguia: None. M. Ross: None. M. Darvish: Allergan, Johnson & Johnson, Santen, Shire. J. Deschênes: AbbVie, Allergan, Imprimis, NIE/NEI, Santen. Shire.Abstract Body: Purpose: Bacterial keratitis is a serious ocular problem that can, if not appropriately treated, lead ...